ArticleVirusdisease2024
Sewage surveillance of SARS-CoV-2 in Tokyo (May 2020-June 2022): method using high-throughput, fully-automated platform.
Article in Virusdisease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is shed in saliva, sputum, and feces of the novel coronavirus disease 2019 (COVID-19) patients, and SARS-CoV-2 RNA has been detected in sewage. Thus, many regions worldwide have implemented the measurement of SARS-CoV-2 RNA in sewage as a monitoring tool for COVID-19 prevalence. Here, we report the monitoring of two wastewater treatment plants in Tokyo from May 2020 to June 2022 using a fully automated genetic testing method for the solid fraction of sewage. We found that SARS-CoV-2 sewage monitoring using the Panther System with the Aptima SARS-CoV-2 Assay Kit is an effective method of qualitative monitoring. Furthermore, spike gene mutations (N501Y, L452R, E484A) by real-time PCR using test residues were detected in some samples, which reflected the epidemic status. Nevertheless, our findings demonstrate that the use of a fully automated testing platform is effective for SARS-CoV-2 RNA detection in the solid fraction of sewage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.